Serum type I and type III procollagen peptide levels in sarcoidosis

被引:8
作者
Bacchella, L
Tinelli, C
Gile, LS
Peona, V
Aprile, C
Gorrini, M
Pasturenzi, L
Cetta, G
Luisetti, M
机构
[1] UNIV PAVIA,POLICLIN SAN MATTEO,IRCCS,IST TOSIOL & MALATTIE RESP,I-27100 PAVIA,ITALY
[2] FDN CLIN LAVORO,NUCL MED SERV,PAVIA,ITALY
[3] UNIV PAVIA,POLICLIN SAN MATTEO,IRCCS,UNITA STAT,I-27100 PAVIA,ITALY
[4] UNIV PAVIA,DIPARTIMENTO BIOCHIM,I-27100 PAVIA,ITALY
关键词
angiotensin-converting enzyme; collagens; granulomata; lung; sarcoidosis activity;
D O I
10.1183/09031936.96.09081648
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Type I and type III are the most abundant collagens in the lung, The aim of our study was to compare type I and III procollagen peptides in sera of sarcoid patients. Sixty eight patients with sarcoidosis were studied (19 with newly recognized disease, 7 with relapsing disease, 15 with chronic disease, and 27 in stable remission), Thirty healthy volunteers served as controls, The levels of procollagen I and III peptides were determined by radioimmunoassay, Angiotensin-converting enzyme (ACE) level was evaluated by means of a colorimetric assay. In patients with newly recognized sarcoidosis, both serum procollagen I and IU. peptide levels were increased with respect to controls (p=0.0014 and p<0.00001, respectively), There was a poor correlation between levels of procollagen I and III (r=0.26), whereas there was a closer correlation between procollagen III and ACE (r=0.69), Procollagen I peptide level did not identify patients in roentgenological stage III. In conclusion, in patients with newly recognized sarcoidosis there is a significant increase in the serum level of procollagen I peptide, However, procollagen I peptide is not a marker of sarcoid patients with fibrosis, ie. stage III disease Its clinical cal usefulness seems to be weaker than that of procollagen III peptide.
引用
收藏
页码:1648 / 1651
页数:4
相关论文
共 25 条
[1]   Polymorphism of angiotensin-converting enzyme gene in sarcoidosis [J].
Arbustini, E ;
Grasso, M ;
Leo, G ;
Tinelli, C ;
Fasani, R ;
Diegoli, M ;
Banchieri, N ;
Cipriani, A ;
Gorrini, M ;
Semenzato, G ;
Luisetti, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (02) :851-854
[2]  
Armitage P., 1971, STAT METHODS MED RES
[3]  
BJERMER L, 1986, LAB INVEST, V55, P654
[4]   RADIOIMMUNOASSAY FOR TYPE-I PROCOLLAGEN IN GROWTH HORMONE DEFICIENT CHILDREN BEFORE AND DURING TREATMENT WITH GROWTH-HORMONE [J].
CAREY, DE ;
GOLDBERG, B ;
RATZAN, SK ;
RUBIN, KR ;
ROWE, DW .
PEDIATRIC RESEARCH, 1985, 19 (01) :8-11
[5]  
COSTABEL U, 1994, EUR RESPIR J, V7, P624
[6]  
COSTABEL U, 1994, LUNG BIOL HEALTH DIS, V73, P429
[7]  
CURULL C, 1994, AM J RESP CRIT CARE, V149, pA606
[8]  
DEREMEE RA, 1985, SARCOIDOSIS, P117
[9]  
HARRISON NK, 1993, EUR RESPIR J, V6, P1443
[10]   AN EVALUATION OF SEVERAL BIOCHEMICAL MARKERS FOR BONE-FORMATION AND RESORPTION IN A PROTOCOL UTILIZING CYCLICAL PARATHYROID-HORMONE AND CALCITONIN THERAPY FOR OSTEOPOROSIS [J].
HODSMAN, AB ;
FRAHER, LJ ;
OSTBYE, T ;
ADACHI, JD ;
STEER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :1138-1148